These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project. Lip GY, Clementy N, Pericart L, Banerjee A, Fauchier L. Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474 [Abstract] [Full Text] [Related]
25. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Viktorsdottir O, Palsson R, Andresdottir MB, Aspelund T, Gudnason V, Indridason OS. Nephrol Dial Transplant; 2005 Sep; 20(9):1799-807. PubMed ID: 15928100 [Abstract] [Full Text] [Related]
26. Validation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in advanced chronic renal failure. Teruel Briones JL, Gomis Couto A, Sabater J, Fernández Lucas M, Rodríguez Mendiola N, Villafruela JJ, Quereda C. Nefrologia; 2011 Sep; 31(6):677-82. PubMed ID: 22130283 [Abstract] [Full Text] [Related]
27. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, Vicente V, Lip GY. Am J Cardiol; 2013 Apr 15; 111(8):1159-64. PubMed ID: 23337836 [Abstract] [Full Text] [Related]
28. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials. Hermsen ED, Maiefski M, Florescu MC, Qiu F, Rupp ME. Pharmacotherapy; 2009 Jun 15; 29(6):649-55. PubMed ID: 19476418 [Abstract] [Full Text] [Related]
29. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G. Nephrol Dial Transplant; 2009 May 15; 24(5):1528-33. PubMed ID: 19073656 [Abstract] [Full Text] [Related]
30. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR. Matsushita K, Tonelli M, Lloyd A, Levey AS, Coresh J, Hemmelgarn BR, Alberta Kidney Disease Network. Am J Kidney Dis; 2012 Aug 15; 60(2):241-9. PubMed ID: 22560843 [Abstract] [Full Text] [Related]
31. Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients. Kooistra HA, Veeger NJ, Khorsand N, Kluin-Nelemans HC, Meijer K, Piersma-Wichers M. Thromb Haemost; 2015 Apr 15; 113(4):881-90. PubMed ID: 25518854 [Abstract] [Full Text] [Related]
32. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D. Thromb Haemost; 2009 May 15; 101(5):938-42. PubMed ID: 19404548 [Abstract] [Full Text] [Related]
33. Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation. Hijazi Z, Granger CB, Hohnloser SH, Westerbergh J, Lindbäck J, Alexander JH, Keltai M, Parkhomenko A, López-Sendón JL, Lopes RD, Siegbahn A, Wallentin L. J Am Heart Assoc; 2020 Sep 15; 9(18):e017155. PubMed ID: 32865097 [Abstract] [Full Text] [Related]
34. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry. Esteve-Pastor MA, Rivera-Caravaca JM, Roldán-Rabadán I, Roldán V, Muñiz J, Raña-Míguez P, Ruiz-Ortiz M, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F, FANTASIIA Study Investigators. Thromb Haemost; 2018 Feb 15; 118(2):279-287. PubMed ID: 29443369 [Abstract] [Full Text] [Related]
35. Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient. Hudson JQ, Nyman HA. Curr Opin Nephrol Hypertens; 2011 Sep 15; 20(5):482-91. PubMed ID: 21709552 [Abstract] [Full Text] [Related]
36. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Lip GYH. Chest; 2014 Jun 15; 145(6):1370-1382. PubMed ID: 24356875 [Abstract] [Full Text] [Related]
37. Relative performance of three formulas to assess renal function at predicting in-hospital hemorrhagic complications in an acute coronary syndrome population. What does the new CKD-EPI formula provide? Cabanas-Grandío P, Abu-Assi E, Raposeiras-Roubin S, Alvarez-Alvarez B, González-Cambeiro C, Romaní SG, Pereira-López E, Bouzas-Cruz N, López-López A, Rodríguez-Girondo M, Pedreira M, García-Acuña JM, González-Juanatey JR. Eur Heart J Acute Cardiovasc Care; 2014 Sep 15; 3(3):237-45. PubMed ID: 24842753 [Abstract] [Full Text] [Related]
38. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. Lip GY, Frison L, Halperin JL, Lane DA. J Am Coll Cardiol; 2011 Jan 11; 57(2):173-80. PubMed ID: 21111555 [Abstract] [Full Text] [Related]
39. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individuals. Camargo EG, Soares AA, Detanico AB, Weinert LS, Veronese FV, Gomes EC, Silveiro SP. Diabet Med; 2011 Jan 11; 28(1):90-5. PubMed ID: 21166850 [Abstract] [Full Text] [Related]
40. Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease. Kooiman J, van Rein N, Spaans B, van Beers KA, Bank JR, van de Peppel WR, del Sol AI, Cannegieter SC, Rabelink TJ, Lip GY, Klok FA, Huisman MV. PLoS One; 2014 Jan 11; 9(5):e94420. PubMed ID: 24817475 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]